Maeva Olive: Infertility Is Not Only an Intimate or Compassionate Subject It’s a Performance Issue
Collectif BAMP Association shared a post by A bout de Taf on LinkedIn:
“Infertility affects 3.3 million people (double the number at the level of the couple).
It is a public health issue, now recognized with the Fertility Plan, but also a challenge for companies. Infertility and ART have a huge impact in the workplace and it is time for companies to take advantage of them.
Maeva Olive, a volunteer with the Collective, talks about it in the A bout de Taf interview with Laure Girardot
If you are a manager, HR, or business leader, contact us for support on this subject!”
Quoting A bout de Taf’s post:
“‘Fertility plan’, public health… And a blind spot in business?
Since the announcement of the fertility plan led by Emmanuel Macron, (and the ‘letter controversy’) the subject has moved out of the strictly intimate sphere to become a public health issue.
Prevention, diagnosis, information: the framework is moving forward! But on the business side, there is a discrepancy according to the 2025 study launched by the Collectif BAMP Association:
- 80% of employers consider the subject important… → but only 35% act, and 5% have structured measures
- 41% of the employees concerned have considered leaving due to a lack of support
- 60% use RTT or leave for their care
- 78% cite a significant impact on their mental health
Translation? A health issue becomes a subject of disengagement, or even a drain of talent.
In the Grand entretien of the week, Maeva Olive (BAMP collective!) puts it this way: ‘Infertility is not only an intimate or compassionate subject. It’s a performance issue.’
What do the most advanced organizations do?
- Formalize a fertility/parenthood policy
- Training managers and HR
- Organising working time and teleworking
- Create spaces for discussion (ERG, referents, occupational medicine) Microsoft
Read it right here.”

Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 29, 2026, 15:58Eric Lameignere: Can DNA Fragmentation in Cumulus Cells Predict ICSI Outcomes?
-
Oct 29, 2026, 15:50Saadat Hassan: Sperm Function Testing – Can Advanced Diagnostics Guide IVF and ICSI Selection?
-
Oct 29, 2026, 15:34Sara Spiro: Celebrating the Stories Members Have Trusted With at Maven Clinic – Here Is Mine
-
Oct 29, 2026, 15:31Dina Ibrahem: 0 Motility, 1 Critical Decision
-
Oct 29, 2026, 15:28AI and Automation in Fertility and Genomics: Pipeline or Pipe Dream? – ARCS
-
Oct 29, 2026, 15:26Michael Schindler: Large Networks or Small Centers – Who Delivers Better Care?
-
Oct 29, 2026, 15:24Denny Sakkas: Driving Innovation in Reproductive Medicine
-
Oct 29, 2026, 15:10From the President’s Gala to Booth 905 at ASRM 2026 – First Fertility
-
Oct 29, 2026, 15:04Proud to Spotlight Dr. Jannie Michielsen and the Expertise She Brings to Every Day – Sims IVF
